Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In VivoReportar como inadecuado

Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Tumor necrosis factor alpha TNF-α plays a key role in inflammation, and its production and signaling contribute to many inflammatory related diseases. Recently, we discovered that selective activation of serotonin 5-HT2A receptors with the agonist R-DOI produces a super-potent blockade of proinflammatory markers in primary rat aortic smooth muscle cells. Here, we demonstrate that systemic administration of R-DOI can block the systemic effects of TNF-α in whole animal, with potent anti-inflammatory effects in the aortic arch and small intestine. This includes blockade of TNF-α-induced expression of pro-inflammatory cell adhesion Icam-1, Vcam-1, cytokine Il-6, IL-1b, and chemokine Mcp-1, Cx3cl1 genes, and expression of VCAM-1 protein in the intestine. Further, systemic R-DOI also prevents the TNF-α-induced increase of circulating IL-6. Importantly, utilizing receptor selective antagonists, we have demonstrated that the mechanism underlying the systemic anti-inflammatory effects of R-DOI is activation of serotonin 5-HT2A receptors. Our results highlight a powerful new role for the serotonin 5-HT2A receptor in inflammatory processes, and indicate that agonism of serotonin receptors may represent an effective and novel approach to develop powerful small molecule therapeutics for inflammatory diseases and conditions such as atherosclerosis and inflammatory bowel disease.

Autor: Felix Nau Jr , Bangning Yu , David Martin, Charles D. Nichols



Documentos relacionados